XIAP and leukemia: In ASCT, differences between MiHA expression in malignant and normal hematopoietic cells of patients and donors, respectively, result in GVHD but also in graft-versus-leukemia (GVL), due to HLA and Killer-cell Immunoglobulin-like Receptor (KIR) mismatches (242, 243).